Orbimed Advisors, Director: Prelude Therapeutics PRLD Buy · Filed 04/23

Trade details

Type: Insider buy
Amount: $4,999,999.44
Shares · price: 1,126,126 sh · $4.44 a share
Held after: 1,126,126 sh
Stock: Prelude Therapeutics PRLD
Person: Orbimed AdvisorsDirector
Trade date: 26/04/21
Filed: 26/04/23
Days to filing: 2 days

First buy in 2 years

Since the last buy: 2.9 years
Last buy: 23/05/22
Insiders buying this week: 5 insiders

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 03/22~05/21

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21

Orbimed Advisors, Director — bought $5M of Prelude Therapeutics PRLD · 1,126,126 sh @ $4.44 | Whalegun